Click to view the earnings moves in BNTX
Can BioNTech’s Stock Buck Its Bearish Earnings-Day Trend?
BioNTech (BNTX) surprised the market today, jumping +3.2% after announcing its second-quarter 2025 earnings. But a look beneath the surface shows that this bullish pop is far from typical for the stock. Is BNTX about to rewrite its usual script—or will history repeat?
Earnings Recap: Surprises and Catalysts
The move comes on the heels of several key updates: BioNTech reaffirmed full-year guidance and highlighted strategic deals, including a $1.5B upfront payment from Bristol Myers Squibb and a planned acquisition of CureVac to boost its mRNA cancer immunotherapy pipeline. These corporate moves and a steady COVID-19 vaccine rollout add new optimism, but did the financial results actually break from past patterns?
Latest reported revenues hit EUR 260.8M for the quarter, up from last year, and net loss was substantially trimmed. For full details, see the company’s report and the earnings event summary here.
Historical Stock Performance: A Pattern of Caution
BNTX has been a tough nut to crack on earnings day. Over the last 12 quarters, the stock has averaged a -1.4% move, with nearly two-thirds of earnings sessions resulting in losses. Even the opening gap—a sign of immediate reaction—has trended negative, and more often than not, the stock has faded further as the day unfolds.
Below is a simplified view of how BNTX has typically performed on and after earnings:
| Stock Performance | Earnings Move | Open Gap | Open to High | Open to Low | Open to Close |
|---|---|---|---|---|---|
| Average Return | -1.4% | -1.2% | +3.0% | -2.8% | -0.2% |
| % of Moves Up | 33.3% | 33.3% | 41.7% | ||
| % of Moves Down | 66.7% | 66.7% | 58.3% |
The average magnitude of these moves can also be seen here, regardless of direction:
| Stock Performance | Earnings Move | Open Gap | Open to High | Open to Low | Open to Close |
|---|---|---|---|---|---|
| Absolute Average Return | 3.4% | 3.7% | 3.0% | 2.8% | 2.5% |
| Max Absolute Return | 7.5% | 6.7% | 6.1% | 5.5% | 5.2% |
| Min Absolute Return | 0.4% | 0.5% | 0.0% | 0.0% | 0.4% |
Want to dig deeper? You can view the full earnings-day historical performance here.
After the Headlines: Does BNTX Keep Drifting Lower?
History also shows a tendency for BNTX to drift after the initial post-earnings reaction. For example, the stock has averaged a loss of -1.2% two days after earnings, and more than 70% of those periods saw the stock decline further. Even so, over a two-week window, the trend sometimes reverses slightly to an average gain of +1.8%.
| Stock Performance | 1 Day After Earnings | 2 Days After Earnings | 3 Days After Earnings | 1 Week After Earnings | 2 Weeks After Earnings |
|---|---|---|---|---|---|
| Average Return | -0.7% | -1.2% | -1.1% | +0.8% | +1.8% |
| % of Moves Up | 54.5% | 27.3% | 27.3% | 36.4% | 36.4% |
| % of Moves Down | 45.5% | 72.7% | 72.7% | 63.6% | 63.6% |
Options Traders: Eye on the August 2025 $120 Call
With 1,084 options traded today (a notable uptick), the single most active contract was the 15-Aug-25 120 C call. This option saw heavy interest, perhaps reflecting new bets that the recent positive news and deals might push the stock higher over the coming year. Here’s a quick glance at the details:
| Attribute | Value |
|---|---|
| Option Contract | 15-Aug-25 120 C |
| Volume | 352 |
| VWAP price | 0.89 |
| Open interest | 1,000 |
| Yesterday's closing price | 0.85 |
Key Takeaways: Caution or Opportunity?
Despite today’s upward move, BNTX’s track record around earnings remains tilted toward disappointment. While positive catalysts and institutional partnerships could be rewriting the narrative, it’s worth asking: Will this rally last or is it another fleeting earnings-day surprise? For anyone watching BioNTech, now may be the time to pay extra attention—not just to headlines, but to the patterns hiding in the numbers.
Ready to do your own homework? Dive deeper into BNTX’s earnings performance history here.
Contact Information:
If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.
About the Publisher - Marketchameleon.com:
Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.
NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.
The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.